相关实验视频
Updated: May 28, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.9K
机器学习对小细胞肺癌患者化疗后早期死亡风险的见解
Min Liang1,2, Fuyuan Luo3
1Department of Respiratory and Critical Care Medicine, Maoming People's Hospital, Maoming, China.
Frontiers in medicine
|February 10, 2025
概括
这项研究开发了一种机器学习模型,用于预测化疗后小细胞肺癌 (SCLC) 患者的90天死亡率,确定改善治疗策略的关键预后特征.
科学领域:
- 在瘤学瘤学.
- 机器学习在医学中的应用
- 生物统计学 生物统计学
背景情况:
- 小细胞肺癌 (SCLC) 具有攻击性,化疗具有显著的毒性和早期死亡风险.
- 量化90天死亡率和识别预测因素对于管理化学治疗后的SCLC患者至关重要.
研究的目的:
- 在接受化疗的SCLC患者中量化90天死亡率.
- 确定与早期死亡相关的临床特征.
- 开发和验证用于预测SCLC患者结果的机器学习模型.
主要方法:
- 利用了12500名SCLC患者的SEER数据库 (2000年至2018年).
- 通过逻辑回归和拉索识别了预后特征.
- 开发了使用XGBoost,MLP,KNN,随机森林,物流回归和AJCC分期的预测模型.
- 评估模型使用AUC,KS统计,校准图表和DCA.
主要成果:
- 确定了10个影响SCLC患者结果的显著临床特征.
- XGBoost模型实现了0.95 (培训) 和0.78 (验证) 的AUC,优于其他模型.
- 该模型展示了卓越的区分和校准能力.
结论:
- 一个新的机器学习模型预测了化学治疗后SCLC患者的90天死亡率.
- 该模型集成到一个网络平台中,帮助医疗保健专业人员进行个性化决策.
- 改进的治疗策略和患者护理是通过这种预测工具促进的.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.8K
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K